citalopram has been researched along with Bacterial Disease in 1 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the characteristics of the linezolid-associated serotonin syndrome cases." | 7.73 | Linezolid-associated serotonin syndrome: what we can learn from cases reported so far. ( Grau, S; Marín-Casino, M; Mateu-de Antonio, J; Morales-Molina, JA, 2005) |
| "To study the characteristics of the linezolid-associated serotonin syndrome cases." | 3.73 | Linezolid-associated serotonin syndrome: what we can learn from cases reported so far. ( Grau, S; Marín-Casino, M; Mateu-de Antonio, J; Morales-Molina, JA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morales-Molina, JA | 1 |
| Mateu-de Antonio, J | 1 |
| Marín-Casino, M | 1 |
| Grau, S | 1 |
1 other study available for citalopram and Bacterial Disease
| Article | Year |
|---|---|
Linezolid-associated serotonin syndrome: what we can learn from cases reported so far.
Topics: Acetamides; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections | 2005 |